Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Steen

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|October 7, 2008
Improving strategies for detecting genetic patterns of disease susceptibility in association studiesM L Calle, V Urrea, G Vellalta, et al.
International Journal of Dental Hygiene|February 3, 2006
Factors related to oral hygiene in persons with sclerodermaJ L Poole, C Brewer, K Rossie, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2004
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximabM Pierik, S Vermeire, K V Steen, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 29, 2013
Pollen markers for gene-centromere mapping in diploid potatoH J Bastiaanssen, M S Ramanna, Z Sawor, et al.
Lupus|December 1, 1995
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USAM C Hochberg, D L Perlmutter, T A Medsger, et al.
Arthritis and Rheumatism|July 1, 1996
Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)M C Hochberg, D L Perlmutter, T A Medsger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancerS Wojtowicz-Praga, J Torri, M Johnson, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Annals of Internal Medicine|June 3, 2000
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trialJ R Seibold, J H Korn, R Simms, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|October 7, 2008
Improving strategies for detecting genetic patterns of disease susceptibility in association studiesM L Calle, V Urrea, G Vellalta, et al.
International Journal of Dental Hygiene|February 3, 2006
Factors related to oral hygiene in persons with sclerodermaJ L Poole, C Brewer, K Rossie, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2004
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximabM Pierik, S Vermeire, K V Steen, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 29, 2013
Pollen markers for gene-centromere mapping in diploid potatoH J Bastiaanssen, M S Ramanna, Z Sawor, et al.
Lupus|December 1, 1995
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USAM C Hochberg, D L Perlmutter, T A Medsger, et al.
Arthritis and Rheumatism|July 1, 1996
Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)M C Hochberg, D L Perlmutter, T A Medsger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancerS Wojtowicz-Praga, J Torri, M Johnson, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Annals of Internal Medicine|June 3, 2000
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trialJ R Seibold, J H Korn, R Simms, et al.
Pageof 3